Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Classificação em ações #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Preço da ação
$0.21291741
Última sincronização: 2025-04-18
Valor de mercado
$12.07M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
KR
Negociar PCL, Inc. (241820)

Categoria

Receita da PCL, Inc. (241820)
Receita em Sep 2025 TTM: $3.55M
De acordo com os últimos relatórios financeiros da PCL, Inc., a receita atual da empresa (TTM) é $3.55M. Em 2023, a empresa obteve uma receita de $6.51M uma diminuição em relação a a receita do ano 2022, que foi de $29.49M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da PCL, Inc. de 2015 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $3.55M 318.67%
2024 $847.63K -86.98%
2023 $6.51M -77.92%
2022 $29.49M -24.02%
2021 $38.82M -21.50%
2020 $49.45M 159,346.74%
2019 $31.01K -73.14%
2018 $115.44K -75.69%
2017 $474.92K -2.74%
2016 $488.29K 136.13%
2015 $206.79K 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$46.59B 1,312,601.74%
US
$25.84B 727,951.41%
US
$35.48B 999,790.71%
IE
$21.00B 591,538.63%
US
$6.51B 183,407.73%
US